CSL Limited (CSJ.F)
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
76.51-0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-48.7%
The outlook
CSL Limited currently reads as leaning bearish based on mixed vs its moving averages, 21% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range21% of the way from its 52-week low to high
Market cap
$36.64B
52-wk high
153.06
52-wk low
56.00
50-day avg
67.47
200-day avg
85.95
Trailing P/E
14.1